Skip to main content
HR 8289 117th Congress House

Banning Misleading Drug Ads Act of 2022

Official title: To require the Secretary of Health and Human Services to promulgate a past due final rule with respect to direct-to-consumer prescription drug advertisements, and for other purposes.

Introduced: October 31, 2022 See on congress.gov
Health
Sign in to write a letter Sign in to watch
This bill died when the 117th Congress ended
It never became law before the 117th Congress (2021–2022) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 5, 2022
Referred to the House Committee on Energy and Commerce.
Jul 5, 2022
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action July 5, 2022

Referred to the House Committee on Energy and Commerce.

 Plain-English summary Congressional Research Service

Banning Misleading Drug Ads Act of 2022

This bill finalizes a 2010 proposed rule from the Food and Drug Administration (FDA) regarding television and radio prescription drug advertisements if the FDA does not otherwise issue a final rule within 180 days of the bill's enactment. (The proposed rule specifies standards for major statements about a drug's side effects in television and radio advertisements.)

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 4
All 4 Democratic 2
D
Norton, Eleanor Holmes
District of Columbia · Oct 31, 2022
Axne, Cynthia
· Jul 5, 2022
 D
Craig, Angie
Minnesota · Jul 5, 2022
Wild, Susan
· Jul 5, 2022
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 8289: Banning Misleading Drug Ads Act of 2022. 117th Congress. Open America. https://openamerica.io/bill/117-HR-8289/
MLA
"H.R. 8289: Banning Misleading Drug Ads Act of 2022." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HR-8289/.
Bluebook (legal)
H.R. 8289, 117th Cong. (2026), https://openamerica.io/bill/117-HR-8289/.
Markdown link
[H.R. 8289: Banning Misleading Drug Ads Act of 2022](https://openamerica.io/bill/117-HR-8289/)
Report a problem